Another debt ceiling debacle could sink the economy
Last year's Congressional debt standoff hurt consumer confidence more than the collapse of Lehman Brothers, Betsey Johnson and Justin Wolfers write. This time could be worse. Read more at Counterparties
Merck obesity drug shows weight loss in study
NEW YORK |
NEW YORK (Reuters) - Merck & Co said on Monday that patients on its experimental obesity drug lost more than twice as much weight as those on a placebo in a late-stage clinical study.
Patients on taranabant lost an average of 14.5 pounds (6.6 kilograms) compared with 5.7 lbs (2.6 kg) for those on a placebo after 52 weeks -- a difference deemed statistically significant, Merck said in a statement.
The findings were presented at the American College of Cardiology conference in Chicago.
(Reporting by Lewis Krauskopf, editing by Gerald E. McCormick)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters